Legal Opinion
Galderma Labs. L.P. v. Teva Pharm. United States, Inc.
District Court, D. Delaware
Decided August 21, 2019No. 17-cv-1783-RGAPublishedCited by 1 opinion
1Opinion of the Court
ANDREWS, U.S. DISTRICT JUDGE
On April 21, 2017, Galderma Laboratories L.P., Galderma S.A., and Nestlé Skin Health S.A. (collectively, "Galderma") brought this action against Teva Pharmaceuticals USA, Inc. for infringement of several patents under 35 U.S.C. § 271(d)(2)(A). (D.I. 1). I held a bench trial from June 10 to 12, 2019. (D.I. 253-56).1 By trial the parties had narrowed the case to three patents- U.S. Patent Nos. 9,089,587 ("the '587 patent"), 9,233,117 ("the '117 patent"), and 9,233,118 ("the '118 patent") (collectively, "the asserted patents").2
Presently before the Court are the…
2Cases cited11 opinions
- Enzo Biochem, Inc. v. Applera Corp.Court of Appeals for the Federal Circuit · 2010
- Nicholas v. Perricone, M.D. v. Medicis Pharmaceutical Corporation, Defendant-CrossCourt of Appeals for the Federal Circuit · 2005
- Hewlett-Packard Company, Plaintiff-Cross v. Mustek Systems, Inc. And Mustek, Inc.Court of Appeals for the Federal Circuit · 2003
- Advanced Display Systems, Inc. v. Kent State UniversityCourt of Appeals for the Federal Circuit · 2000
- Callaway Golf Co. v. Acushnet Co.Court of Appeals for the Federal Circuit · 2009
6 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Galderma Laboratories v. Teva Pharmaceuticals USACourt of Appeals for the Federal Circuit · 2020